170 related articles for article (PubMed ID: 11858960)
1. Scientific review of EORTC trials: the functioning of the New Treatment Committee and Protocol Review Committee.
Lardot C; Steward W; Van Glabbeke M; Armand JP
Eur J Cancer; 2002 Mar; 38 Suppl 4():S24-30. PubMed ID: 11858960
[TBL] [Abstract][Full Text] [Related]
2. The EORTC clinical research coordinators group. European Organisation for Research and Treatment of Cancer.
Fishwick K; Berridge J; Coffey M; Colussi AM; Di Giulio P; Marinus A; Molin C; Peters M
Eur J Cancer; 2002 Mar; 38 Suppl 4():S54-9. PubMed ID: 11858966
[TBL] [Abstract][Full Text] [Related]
3. The EORTC and drug development. European Organisation for Research and Treatment of Cancer.
Lacombe D; Fumoleau P; Zwierzina H; Twelves C; Hakansson L; Jayson G; Lehmann F; Verweij J; ;
Eur J Cancer; 2002 Mar; 38 Suppl 4():S19-23. PubMed ID: 11858959
[TBL] [Abstract][Full Text] [Related]
4. The EORTC Laboratory Research Division. European Organisation for Research and Treatment of Cancer.
Brünner N; Double J; Fichtner I; Gescher A; Newell D; Oosterhuis W; Price P
Eur J Cancer; 2002 Mar; 38 Suppl 4():S14-8. PubMed ID: 11858958
[TBL] [Abstract][Full Text] [Related]
5. European Ethical Review Committee: the experience of an international ethics committee reviewing protocols for drug trials.
Faccini JM; Bennett PN; Reid JL
Br Med J (Clin Res Ed); 1984 Oct; 289(6451):1052-4. PubMed ID: 6435770
[TBL] [Abstract][Full Text] [Related]
6. The EORTC Gastrointestinal Tract Cancer Group: 40 years of research contributing to improved GI cancer management.
Anak O; Van Cutsem E; Nordlinger B
Eur J Cancer; 2002 Mar; 38 Suppl 4():S65-70. PubMed ID: 11858968
[TBL] [Abstract][Full Text] [Related]
7. Variability among institutional review boards and the value of local research context.
Clark DC
Crit Care Med; 2001 Feb; 29(2):444-5. PubMed ID: 11246330
[No Abstract] [Full Text] [Related]
8. The EORTC Breast Cancer Group: 40 years of research contributing to improve breast cancer management.
Therasse P; Piccart M; van de Velde CJ; Jassem J;
Eur J Cancer; 2002 Mar; 38 Suppl 4():S39-43. PubMed ID: 11858963
[TBL] [Abstract][Full Text] [Related]
9. Radiation Therapy Oncology Group. Research Plan 2002-2006. Surgical Oncology Committee.
Ginsburg R; Bullard D; Eisenberg B; Gomella L; Johnstone D; Pisters PW; Sigurdson E; Weber R; Levenback C;
Int J Radiat Oncol Biol Phys; 2001; 51(3 Suppl 2):92-5. PubMed ID: 11641022
[No Abstract] [Full Text] [Related]
10. The role of the EORTC pathologist in clinical trials: achievements and perspectives. European Organisation for Research and Treatment of Cancer.
Spatz A; Ruiter DJ; Busch C; Theodorovic I; Oosterhuis JW
Eur J Cancer; 2002 Mar; 38 Suppl 4():S120-4. PubMed ID: 11858977
[TBL] [Abstract][Full Text] [Related]
11. Phase II trials in the EORTC. The Protocol Review Committee, the Data Center, the Research and Treatment Division, and the New Drug Development Office. European Organization for Research and Treatment of Cancer.
Eur J Cancer; 1997 Aug; 33(9):1361-3. PubMed ID: 9337674
[TBL] [Abstract][Full Text] [Related]
12. Radiation Therapy Oncology Group. Research Plan 2002-2006. Medical Oncology Committee.
Ajani J; Ettinger D; Kelsen DP; Hudis C; Kudelka A; Langer C; Pienta K; Safran H; Vokes EE; Yung WK;
Int J Radiat Oncol Biol Phys; 2001; 51(3 Suppl 2):88-91. PubMed ID: 11641021
[No Abstract] [Full Text] [Related]
13. Cancer drug development in Europe: a selection of new agents under development at the European Drug Development Network.
Lacombe D; Butler-Smith A; Therasse P; Fumoleau P; Burtles S; Calvert H; Marsoni S; Sessa C; Verweij J
Cancer Invest; 2003; 21(1):137-47. PubMed ID: 12643015
[TBL] [Abstract][Full Text] [Related]
14. Regulatory issues for clinical trials at EORTC: the way forward. European Organisation for Research and Treatment of Cancer.
Baeyens AJ; Lacombe D
Eur J Cancer; 2002 Mar; 38 Suppl 4():S142-6. PubMed ID: 11858981
[TBL] [Abstract][Full Text] [Related]
15. EORTC Brain Tumor Group: achievements and perspectives.
Vecht ChJ; van den Bent MJ; Lacombe D
Eur J Cancer; 2002 Mar; 38 Suppl 4():S35-8. PubMed ID: 11858962
[TBL] [Abstract][Full Text] [Related]
16. The EORTC Boron Neutron Capture Therapy (BNCT) Group: achievements and future projects.
Sauerwein W; Zurlo A;
Eur J Cancer; 2002 Mar; 38 Suppl 4():S31-4. PubMed ID: 11858961
[TBL] [Abstract][Full Text] [Related]
17. Health Economics Unit achievements.
Crott R; Neymark N
Eur J Cancer; 2002 Mar; 38 Suppl 4():S147-50. PubMed ID: 11858982
[TBL] [Abstract][Full Text] [Related]
18. The EORTC Melanoma Group: a comprehensive melanoma research programme by clinicians and scientists. European Organisation for Research and Treatment of Cancer.
Eggermont AM; Keilholz U; Autier P; Ruiter DJ; Lehmann F; Lienard D;
Eur J Cancer; 2002 Mar; 38 Suppl 4():S114-9. PubMed ID: 11858976
[TBL] [Abstract][Full Text] [Related]
19. Radiation Therapy Oncology Group. Research Plan 2002-2006. Cancer Prevention and Control Committee.
Scarantino C; Berk L; David F; Fisher J; Griffin P; Hartsell W; Konski A; Kuske R; Pilipich M; Scarantino C; Scott C; Sperduto P;
Int J Radiat Oncol Biol Phys; 2001; 51(3 Suppl 2):113-9. PubMed ID: 11641026
[No Abstract] [Full Text] [Related]
20. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
